News

The Lleida researcher Ferran Barbé, the third most influential scientist in the international community in the field of sleep apnoea.

According to research that has analysed the 100 most cited articles in the medical literature

The Lleida researcher Ferran Barbé, the third most influential scientist in the international community in the field of sleep apnoea.

Presentation of the book 'L'univers divers' on minority diseases at the Lleida Public Library

By the author, Alba Bellart, and the head of Promotion at IRBLleida, Josep Maria Bosch

Presentation of the book 'L'univers divers' on minority diseases at the Lleida Public Library

A clinical trial with calcitriol has begun to validate its therapeutic potential for treating Friedreich's Ataxia

Friedreich's ataxia is a minority neurodegenerative disease characterised by difficulty in coordinating movements

A clinical trial with calcitriol has begun to validate its therapeutic potential for treating Friedreich's Ataxia

Solutioma, new collaborating company of the IRBLleida

To promote biomedical research in Lleida

Solutioma, new collaborating company of the IRBLleida

MicroRNA profile defined as a biomarker to predict progression of COVID-19 in severe patients

According to research led in Lleida by the Translational Research in Respiratory Medicine group at IRBLleida, the University of Lleida, the Arnau de Vilanova and Santa Maria de Lleida Hospitals, and CIBERES

MicroRNA profile defined as a biomarker to predict progression of COVID-19 in severe patients

Paeria and IRBLleida are working on a community project to screen young people in Lleida for Chlamydia bacterium infections

The proposal is to carry out a community project to improve the detection and study of the prevalence of asymptomatic infections

Paeria and IRBLleida are working on a community project to screen young people in Lleida for Chlamydia bacterium infections